"The Jacqueline M. Wilentz Comprehensive Breast Center is committed to meeting the breast health needs of all women. We provide a comfortable and supportive setting where all outpatient breast health care services are provided in one convenient location—from routine mammography screenings to the early detection and treatment of breast cancer or benign breast disease."

During the past decade, Rutgers Cancer Institute of New Jersey,600 River Avenue conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rutgers Cancer Institute of New Jersey,600 River Avenue" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Rutgers Cancer Institute of New Jersey,600 River Avenue" are "Triple Negative Breast Cancer" (2 trials), "PD-L1 Negative" (1 trials) and "PD-L1 Positive" (1 trials). Many other conditions were trialed in "Rutgers Cancer Institute of New Jersey,600 River Avenue" in a lesser frequency.

Most popular intervention types in "Rutgers Cancer Institute of New Jersey,600 River Avenue" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Gemcitabine" (2 trials), "Paclitaxel" (2 trials), "Sacituzumab Govitecan-hziy" (2 trials) and "nab-Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rutgers Cancer Institute of New Jersey,600 River Avenue" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Rutgers Cancer Institute of New Jersey,600 River Avenue". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Rutgers Cancer Institute of New Jersey,600 River Avenue, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rutgers Cancer Institute of New Jersey,600 River Avenue, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".